RANCHO CORDOVA, Calif.,
Aug. 5, 2021 /PRNewswire/ --
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in
automated cell processing tools and services in the cell and gene
therapy field, today announced that the Company will
release its financial results for the second quarter ended
June 30, 2021 and provide a corporate
strategic update on Thursday, August 12,
2021, after the close of trading. A conference call and
webcast will follow at 1:30 p.m. PT/
4:30 p.m. ET.
To participate in the conference call, please dial
1-844-889-4331 (domestic), 1-412-380-7406 (international)
or 1-866-605-3852 (Canada).
To access a live webcast of the call, please
visit: https://thermogenesis.com/investors/news-and-events/events-webcasts.
A webcast replay will be available on ThermoGenesis' website for
three months by visiting the Investor page of the Company's website
at www.thermogenesis.com.
About ThermoGenesis Holdings, Inc.
ThermoGenesis
Holdings, Inc. develops, commercializes, and markets a range of
automated technologies for CAR-T and other cell-based therapies.
The Company currently markets a full suite of solutions for
automated clinical biobanking, point-of-care applications, and
automation for immuno-oncology, including its semi-automated,
functionally-closed CAR-TXpress™ platform, which streamlines
the manufacturing process for the emerging CAR-T immunotherapy
market. For more information about ThermoGenesis, please
visit: www.thermogenesis.com.
Company Contact:
Wendy
Samford
916-858-5191
ir@ThermoGenesis.com
Investor Contact:
Paula Schwartz, Rx
Communications
917-322-2216
pschwartz@rxir.com
View original
content:https://www.prnewswire.com/news-releases/thermogenesis-holdings-to-announce-financial-results-for-the-second-quarter-ended-june-30-2021-and-provide-a-corporate-strategic-update-301349669.html
SOURCE ThermoGenesis Holdings, Inc.